The insulin‐like growth factor binding protein–microfibrillar associated protein–sterol regulatory element binding protein axis regulates fibroblast–myofibroblast transition and cardiac fibrosis
- 8 April 2024
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 181 (15) , 2492-2508
Abstract
Background and Purpose: Excessive fibrogenesis is associated with adverse cardiac remodelling and heart failure. The myofibroblast, primarily derived from resident fibroblast, is the effector cell type in cardiac fibrosis. Megakaryocytic leukaemia 1 (MKL1) is considered the master regulator of fibroblast–myofibroblast transition (FMyT). The underlying transcriptional mechanism is not completely understood. Our goal was to identify novel transcriptional targets of MKL1 that might regulate FMyT and contribute to cardiac fibrosis.Experimental Approach: RNA sequencing (RNA‐seq) performed in primary cardiac fibroblasts identified insulin‐like growth factor binding protein 5 (IGFBP5) as one of the genes most significantly up‐regulated by constitutively active (CA) MKL1 over‐expression. IGFBP5 expression was detected in heart failure tissues using RT‐qPCR and western blots.Key Results: Once activated, IGFBP5 translocated to the nucleus to elicit a pro‐FMyT transcriptional programme. Consistently, IGFBP5 knockdown blocked FMyT in vitro and dampened cardiac fibrosis in mice. Of interest, IGFBP5 interacted with nuclear factor of activated T‐cell 4 (NFAT4) to stimulate the transcription of microfibril‐associated protein 5 (MFAP5). MFAP5 contributed to FMyT and cardiac fibrosis by enabling sterol response element binding protein 2 (SREBP2)‐dependent cholesterol synthesis.Conclusions and Implications: Our data unveil a previously unrecognized transcriptional cascade, initiated by IGFBP5, that promotes FMyT and cardiac fibrosis. Screening for small‐molecule compounds that target this axis could yield potential therapeutics against adverse cardiac remodelling.Keywords
Funding Information
- National Natural Science Foundation of China (82121001, 82100286, 82260052, 82300298)
- Natural Science Foundation of Hainan Province (821QN0988)
This publication has 49 references indexed in Scilit:
- High glucose stimulating ECM remodeling and an inflammatory phenotype in the IPFP via upregulation of MFAP5 expressionBiochemical and Biophysical Research Communications, 2022
- Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur studyEBioMedicine, 2021
- MFAP5is related to obesity-associated adipose tissue and extracellular matrix remodeling and inflammationObesity, 2015
- A TRPC6-Dependent Pathway for Myofibroblast Transdifferentiation and Wound Healing In VivoDevelopmental Cell, 2012
- Overexpression of insulin like growth factor binding protein 5 reduces liver fibrosis in chronic cholangiopathyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Simvastatin preserves diastolic function in experimental hypercholesterolemia independently of its lipid lowering effectAtherosclerosis, 2011
- Redox-sensitive myocardial remodeling and dysfunction in swine diet-induced experimental hypercholesterolemiaAtherosclerosis, 2007
- Insulin‐like growth factor binding protein 5 induces skin fibrosis: A novel murine model for dermal fibrosisArthritis & Rheumatism, 2006
- Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril‐associated glycoprotein 2 and type I collagenArthritis & Rheumatism, 2004
- Causal relationship between occlusive lesions of the coronary artery and myocardial fibrosis in arteriosclerotic rabbits —differences between cholesterol-fed and heritable hyperlipidemic rabbitsAtherosclerosis, 1996